期刊
EXPERIMENTAL DERMATOLOGY
卷 22, 期 7, 页码 476-481出版社
WILEY-BLACKWELL
DOI: 10.1111/exd.12187
关键词
adalimumab; IL-17A; p38 MAPK; S100A8; TNF alpha
类别
资金
- Aage Bang Foundation
- Danish Psoriasis Research Foundation
The antimicrobial peptide S100A8 is known to be upregulated in lesional psoriatic skin compared with non-lesional psoriatic skin and is believed to play a role in the pathogenesis of psoriasis. However, little is known about the signalling pathways involved in the regulation of S100A8 expression. Using quantitative real-time RT-PCR analysis, we demonstrated that stimulation with TNF and IL-17A in combination resulted in a significant and synergistic induction of S100A8 mRNA in human keratinocytes. TNF and IL-17A also induced the S100A8 promoter activity synergistically. This was demonstrated by a gene reporter assay in cells transfected with a luciferase plasmid construct, consisting of 3502 base pairs of the human S100A8 promoter. The TNF- and IL-17A-mediated induction of S100A8 mRNA and protein was mediated by a p38 MAPK-dependent mechanism, as demonstrated by the use of a p38 MAPK inhibitor. Finally, adalimumab treatment for patients with psoriasis significantly decreased S100A8 mRNA at day fourteen after start of treatment, but not at day four. Taken together, this study demonstrates that the p38 MAPK signalling pathway plays a key role in the TNF- and IL-17A-induced expression of S100A8 in cultured human keratinocytes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据